MedPath

VGX PHARMACEUTICALS, LLC

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:4

Trial Phases

2 Phases

Phase 1:2
Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)β€’ Click on a phase to view related trials

Phase 1
2 (50.0%)
Phase 2
2 (50.0%)

Multiple-Dose Study of VGX-1027 in Healthy Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-09-26
Last Posted Date
2009-04-07
Lead Sponsor
VGX Pharmaceuticals, LLC
Target Recruit Count
40
Registration Number
NCT00760396
Locations
πŸ‡ΊπŸ‡Έ

SNBL Clinical Pharmacology Center, Inc., Baltimore, Maryland, United States

Phase I Safety and Pharmacokinetic Study of VGX-1027 in Healthy Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-02-29
Last Posted Date
2009-01-09
Lead Sponsor
VGX Pharmaceuticals, LLC
Target Recruit Count
48
Registration Number
NCT00627120
Locations
πŸ‡ΊπŸ‡Έ

SNBL Clinical Pharmacology Center, Baltimore, Maryland, United States

Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects

Phase 2
Completed
Conditions
HIV Infections
Interventions
Drug: VGX-410 (Mifepristone)
Drug: Placebo for VGX-410 (Mifepristone)
First Posted Date
2006-07-17
Last Posted Date
2010-03-09
Lead Sponsor
VGX Pharmaceuticals, LLC
Target Recruit Count
19
Registration Number
NCT00352911
Locations
πŸ‡ΊπŸ‡Έ

Georgetown University, Washington, District of Columbia, United States

πŸ‡ΊπŸ‡Έ

University of Pennsylvania, Philadelphia, Pennsylvania, United States

πŸ‡ΊπŸ‡Έ

Veterans Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients

Phase 2
Completed
Conditions
Hepatitis C Virus Infection
Interventions
Drug: VGX-410 (Mifepristone)
Drug: Placebo
First Posted Date
2005-11-17
Last Posted Date
2009-11-03
Lead Sponsor
VGX Pharmaceuticals, LLC
Target Recruit Count
44
Registration Number
NCT00255177
Locations
πŸ‡ΊπŸ‡Έ

University of Connecticut, Farmington, Connecticut, United States

πŸ‡ΊπŸ‡Έ

Orlando Clinical Research Center, Orlando, Florida, United States

πŸ‡ΊπŸ‡Έ

Saint Louis University, Saint Louis, Missouri, United States

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.